Skip to main content
TipRanks
Go Ultimate75% OFF

CK Life Sciences International (Holdings), Inc. (0775) Stock Price & Analysis

4 Followers

0775 Stock Chart & Stats

HK$0.53-HK$0.01(-1.87%)
At close: 4:00 PM GMT+8
HK$0.5HK$0.55HK$0.6Aug 24Sep 7Sep 21Oct 5Oct 20Nov 2Nov 16
Day’s Range
HKD 0.52 - HKD 0.54
52-Week Range
HKD 0.49 - HKD 0.90
Previous Close
HKD 0.54
Volume
N/A
Average Volume (3M)
1.57M
Market Cap
HKD 5.14B
Enterprise Value
HKD 11.92B
Total Cash (Recent Filing)
HKD 535.65M
Total Debt (Recent Filing)
HKD 6.83B
Price to Earnings (P/E)
―
Beta
0.70
Next Earnings
Mar 16, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Diversified Life-Science Activities

Operating across environmental solutions and health-related products gives CK Life Sciences more than one avenue for revenue generation. This breadth can help the company serve different customer needs and reduce reliance on a single product category over the next several quarters.

In-House R&D And Commercialization

In-house research and commercialization capabilities provide a foundation for developing, improving, and scaling life-science products. If execution remains effective, these capabilities can support product renewal and market expansion without relying solely on external innovation.

Meaningful Equity Base

A meaningful equity base and stable asset foundation provide some balance-sheet support despite recent losses and elevated leverage. This capital cushion may help the company continue operating and fund selected priorities while management works to restore profitability and cash generation.

Bears Say

Sharp Profitability Deterioration

The sharp margin contraction and move into operating losses indicate that the current business mix is generating materially weaker economics. Unless margins recover, reduced profitability will constrain reinvestment, weaken earnings resilience, and make sustained growth harder to achieve.

Negative Cash Generation

The reversal from consistently positive operating cash flow during 2020–2024 to negative operating cash flow and substantial free-cash-flow outflow increases funding pressure. Persistently weak cash conversion would reduce flexibility for investment, debt service, and shareholder returns.

Elevated And Rising Leverage

Leverage at roughly 1.75 times equity leaves the company more exposed while profitability and cash generation are weak. Higher debt relative to equity can increase financing demands and restrict capital allocation, making recovery more dependent on improved operating results.

CK Life Sciences International (Holdings), Inc. News

0775 FAQ

What was CK Life Sciences International (Holdings), Inc.’s price range in the past 12 months?
CK Life Sciences International (Holdings), Inc. lowest stock price was HK$0.49 and its highest was HK$0.90 in the past 12 months.
What is CK Life Sciences International (Holdings), Inc.’s market cap?
CK Life Sciences International (Holdings), Inc.’s market cap is HK$5.14B.
When is CK Life Sciences International (Holdings), Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CK Life Sciences International (Holdings), Inc.’s earnings last quarter?
CK Life Sciences International (Holdings), Inc. released its earnings results on Aug 11, 2026. The company reported -HK$0.003 earnings per share for the quarter.
Is CK Life Sciences International (Holdings), Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does CK Life Sciences International (Holdings), Inc. pay dividends?
CK Life Sciences International (Holdings), Inc. pays an annual dividend of HK$0.008 which represents an annual dividend yield of ―. See more information on CK Life Sciences International (Holdings), Inc. dividends here
What is CK Life Sciences International (Holdings), Inc.’s EPS estimate?
CK Life Sciences International (Holdings), Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CK Life Sciences International (Holdings), Inc. have?
CK Life Sciences International (Holdings), Inc. has 9,611,072,000 shares outstanding.
What happened to CK Life Sciences International (Holdings), Inc.’s price movement after its last earnings report?
CK Life Sciences International (Holdings), Inc. reported an EPS of -HK$0.003 in its last earnings report. Following the earnings report the stock price went down -1.724%.
Which hedge fund is a major shareholder of CK Life Sciences International (Holdings), Inc.?
Currently, no hedge funds are holding shares in HK:0775
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology